911±¬ÁÏÍø

DuPont Pioneer Gains Exclusive License for Genome-Editing Technology from 911±¬ÁÏÍø

Sukurta: 25 June 2015

DuPont Pioneer Gains Exclusive License for Genome-Editing Technology from 911±¬ÁÏÍøDuPont Pioneer (DuPont) announced a technology license and research collaboration agreement with 911±¬ÁÏÍø earlier this week to further the technical and commercial utility of guided Cas9 genome editing technology.

Under the agreement, DuPont receives an exclusive license to 911±¬ÁÏÍø intellectual property for all commercial uses, including in agriculture. In addition, 911±¬ÁÏÍø and DuPont have entered into a multi-year research collaboration to advance the development of the technology.

A team of scientists from the 911±¬ÁÏÍø Institute of Biotechnology was one of the first groups to discover that the Cas9 protein could be repurposed to precisely edit targeted sections of an organism’s DNA to achieve a specific outcome. In plants, this can include promoting drought tolerance and disease resistance for protecting plant health and increasing crop yields.

Full version of news release is presented here.